SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Oscient Pharmaceuticals Corp. (OSCI)

 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Richaaard who wrote (526)1/10/2000 11:42:00 AM
From: Starlight  Read Replies (1) of 1154
 
Thanks, Richard. Earnings expected on GENE soon:

Editor's Note: Welcome to On Tap Today,
TheStreet.com's effort to give you an quick read on
scheduled events to watch for each trading day. We
look forward to making this a richly informative,
one-stop resource to help you get your day started.
As always, your feedback is welcome. Feel free to
shoot me an email at jedwards@thestreet.com.

-- John J. Edwards III
Markets Editor

The big news of the day will be the December
employment report, with economists expecting a
similar amount of new jobs and the same
unemployment rate as in November. A surprise on
the upside in payrolls would likely roil the bond
market, but a corresponding stock-market selloff
could lend some strength to fixed-income. (For
more on that, see TheStreet.com's jobs report
preview.)

Expected Earnings Reports

(Expectations and estimates as reported by First
Call/Thomson Financial. Unless specified, the
first quarter ends in March, the second in June, the
third in September and the fourth -- you guessed it
-- in December. Figures are per-share.)

Possibly reporting:

Genome Therapeutics (GENE:Nasdaq -
news), first quarter (November). Estimate:
loss 5 cents. Year-ago: loss 13 cents.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext